Details of the Drug Formulations

General Information of Drug (ID: DMWQ16I)

• Drug Name: Primaquine Drug Info
• Synonyms: Kanaprim; Primachin; Primachina; Primachinum; Primaquin; Primaquina; Primaquinum; Primachina [DCIT]; SN 13272; WR 2975; Dl-Primaquine; Kanaprim (TN); Neo-Quipenyl; Primaquina [INN-Spanish]; Primaquine (INN); Primaquine Bis-Phosphoric Acid; Primaquine [INN:BAN]; Primaquinum [INN-Latin]; SN 13,272; TG1-296; TG1-297; Ethylbutylamino)-6-methoxyquinoline; S. N. 13272; N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine; Quinoline, 8-(4-amino-1-methylbutylamino)-6-methoxy; N(4)-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; N-(5-aminopentan-2-yl)-6-methoxyquinolin-8-amine; N~4~-[6-(methyloxy)quinolin-8-yl]pentane-1,4-diamine; Quinoline, 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-(6CI,8CI); (+)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine; (+)-Primaquine; (+/-)-Primaquine; (-)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine; (-)-Primaquine; 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-(9CI); 4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine; 6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline; 6-Methoxy-8-[(4-amino-1-methylbutyl)amino]quinoline; 6-Methoxy-8-[4-amino-1-methylbutylamino]quinoline; 8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline; 8-(4-Amino-1-m; 8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline; 8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline

Indication

Disease Entry	ICD 11	Status	REF
Malaria	1F40-1F45	Approved	[1]

• Therapeutic Class: Antimalarials
• Cross-matching ID:
  PubChem CID: 4908
  ChEBI ID: CHEBI:8405
  CAS Number: 90-34-6
  TTD ID: D0T1LK
  INTEDE ID: DR1339
  ACDINA ID: D00554

Full List of Drug Formulations Containing This Drug

Primaquine 26.3 mg tablet

Company	Formulation ID	FDA Description
Alvogen	F17865	Lactose monohydrate; Fd&c red no. 40; Fd&c blue no. 2; Fd&c yellow no. 5; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Starch, corn
Aidarex Pharmaceuticals; Bayshore Pharmaceuticals; Liberty Pharmaceuticals; PD-Rx Pharmaceuticals	F17861	Lactose monohydrate; Fd&c red no. 40; Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Water; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Starch, corn
Golden State Medical Supply	F17864	Lactose monohydrate; Fd&c red no. 40; Fd&c blue no. 2; Magnesium stearate; Titanium dioxide; Water; Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol, unspecified; Starch, corn
Ingenus Pharmaceuticals	F17863	Lactose monohydrate; Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Triacetin; Cellulose, microcrystalline; Hypromellose 2910 (15 mpa.s); Starch, pregelatinized corn
PD-Rx Pharmaceuticals	F17860	Lactose; Magnesium stearate; Ferric oxide red; Talc; Titanium dioxide; Polyethylene glycol 400; Polysorbate 80; Carnauba wax; Cellulose, microcrystalline; Hypromellose 2910 (15000 mpa.s); Starch, corn
Avera McKennan Hospital; Bryant Ranch Prepack; Sanofi-Aventis	F17862	Lactose, unspecified form; Magnesium stearate; Ferric oxide red; Talc; Titanium dioxide; Polyethylene glycol 400; Polysorbate 80; Carnauba wax; Hypromellose 2910 (15000 mpa.s); Microcrystalline cellulose; Starch, corn

References

• [1] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 008316.